Navigation Links
Harvard scientists bend nanowires into 2-D and 3-D structures
Date:10/21/2009

CAMBRIDGE, Mass., Oct. 21, 2009 -- Taking nanomaterials to a new level of structural complexity, scientists have determined how to introduce kinks into arrow-straight nanowires, transforming them into zigzagging two- and three-dimensional structures with correspondingly advanced functions.

The work is described this week in the journal Nature Nanotechnology by Harvard University researchers led by Bozhi Tian and Charles M. Lieber.

Among other possible applications, the authors say, the new technology could foster a new nanoscale approach to detecting electrical currents in cells and tissues.

"We are very excited about the prospects this research opens up for nanotechnology," says Lieber, Mark Hyman, Jr. Professor of Chemistry in Harvard's Faculty of Arts and Sciences. "For example, our nanostructures make possible integration of active devices in nanoelectronic and photonic circuits, as well as totally new approaches for extra- and intracellular biological sensors. This latter area is one where we already have exciting new results, and one we believe can change the way much electrical recording in biology and medicine is carried out."

Lieber and Tian's approach involves the controlled introduction of triangular "stereocenters" -- essentially, fixed 120 joints -- into nanowires, structures that have previously been rigidly linear. These stereocenters, analogous to the chemical hubs found in many complex organic molecules, introduce kinks into 1-D nanostructures, transforming them into more complex forms.

The researchers were able to introduce stereocenters as nanowires self-assembled. They halted growth of the 1-D nanostructures for 15 seconds by removing key gaseous reactants from the chemical brew in which the process was taking place, replacing these reactants after joints had been introduced into the nanostructures. This approach resulted in a 40 percent yield of bent nanowires, which can then be purified to achieve higher yields.

"The stereocenters appear as 'kinks,' and the distance between kinks is completely controlled," says Tian, a research assistant in Harvard's Department of Chemistry and Chemical Biology. "Moreover, we demonstrated the generality of our approach through synthesis of 2-D silicon, germanium, and cadmium sulfide nanowire structures."

The research by Lieber and Tian is the latest in a years-long effort by scientists to control the composition and structure of nanowires during synthesis. Despite advances in these areas, the ability to control the design and growth of self-assembling nanostructures has been limited.

Lieber and Tian's work takes the formation of 2-D nanostructures a step further by enabling the introduction of electronic devices at the stereocenters.

"An important concept that emerged from these studies is that of introducing functionality at defined nanoscale points for the first time -- in other words, nanodevices that can 'self-label,'" Lieber says. "We illustrated this novel capability by the insertion of pn diodes and field-effect transistors precisely at the stereocenters."

Such self-labeled structures could open up the possibility of introducing nanoelectronics, photodetectors, or biological sensors into complex nanoscale structures.


'/>"/>

Contact: Steve Bradt
steve_bradt@harvard.edu
617-496-8070
Harvard University
Source:Eurekalert  

Related biology technology :

1. Genedata Screener Supports Small Molecule Research at the Broad Institute of Harvard and MIT
2. Confirmation of Bogoch Replikins Influenza Patents by Harvard-CDC and Scripps-Crucell Data
3. RainDance Technologies and Harvard University to Share in First Massachusetts Life Sciences Center Cooperative Research Grants
4. bwin and Harvard Medical School Faculty Sign 5-Year Research Cooperation Agreement
5. Isilon CTO Addresses Life Science Data Storage Challenges at Harvard Medical Schools BioMedical HPC Leadership Summit
6. HistoRx Announces Expanded Access of AQUA(R) Technology to 900+ Researchers at Dana-Farber/Harvard Cancer Center
7. Open Biosystems Open Access RNAi Program Adopted by Harvard Medical School and University of North Carolina
8. Egenix Licenses Harvard Anti-Cancer Platform
9. Harvard University engineers demonstrate quantum cascade laser nanoantenna
10. FDA and Conformia Deliver Joint Presentation to Annual Regulatory and Compliance Symposium at Harvard
11. Scientists use math modeling to predict unknown biological mechanism of regulation
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Harvard scientists bend nanowires into 2-D and 3-D structures
(Date:2/16/2017)...  ArmaGen, Inc., a privately held biotechnology company ... neurological disorders, today reported preliminary evidence of cognitive ... investigational therapy for the treatment of Hurler and ... or MPS I). The initial results from an ... at the 13 th annual WORLD Symposium ...
(Date:2/16/2017)... , Feb. 16, 2017   Capricor ... a clinical-stage biotechnology company developing first-in-class biological therapies ... that it has elected to terminate its license ... peptide receptor agonists, including Cenderitide. "Our ... move as we prioritize our efforts to advance ...
(Date:2/16/2017)... PALM BEACH, Florida , February 16, 2017 ... vastly improving with the infusion of innovative telemedicine ... patient monitoring services that are experiencing a boom ... evolve with the advancement of technologies, services and ... Technologies Inc. (OTC: RQHTF) (TSX-V: RHT), Cellectar Biosciences, ...
(Date:2/16/2017)... 16, 2017  Dermata Therapeutics, LLC, a biotechnology ... a variety of dermatological diseases, today announced it ... and entered into a $5 million credit facility ... use the capital for general corporate purposes to ... the treatment of serious diseases treated by dermatologists. ...
Breaking Biology Technology:
(Date:2/10/2017)... Research and Markets has announced the addition ... and Commercial Aspects" to their offering. ... Biomarkers play an ... for selection of treatment as well for monitoring the results. ... in modern medicine. Biochip/microarray technologies and next generation sequencing are ...
(Date:2/8/2017)... -- Report Highlights ... The global synthetic-biology market reached nearly $3.9 billion ... at a compound annual growth rate (CAGR) of 24.0% through ... markets for synthetic biology. - Analyses of global market trends, ... compound annual growth rates (CAGRs) through 2021. - Coverage of ...
(Date:2/7/2017)... 7, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... will present at the LEERINK Partners 6th Annual Global ... on Wednesday, February 15, 2017 at 10 a.m. Eastern ... presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  The ... via Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com ...
Breaking Biology News(10 mins):